HomeAbout JournalEditorial BoardSubmission GuidelinesSubscriptionContact UsChinese
Quote : 詹和道,姚江凌,崔红旺.连翘酯苷A对IL-1β诱导的软骨细胞损伤的影响[J].湖南中医药大学学报英文版,2023,43(8):1402-1407.[Click to copy ]
【Print 】      【Download PDF 】   【View/Add Comment】  【Download reader】  【 Close 】
←Previous |Next→ Archive    Advanced Search
This paper :Browser 3066times   Download 1481times
连翘酯苷A对IL-1β诱导的软骨细胞损伤的影响
詹和道,姚江凌,崔红旺
(海南医学院第一附属医院, 海南 海口 570102)
摘要:
    目的 探讨连翘酯苷A对白细胞介素-1β(interleukin-1β,IL-1β)诱导的软骨细胞损伤的影响及其可能的作用机制。方法 采用50 mg/L IL-1β诱导人关节软骨细胞建立细胞损伤模型,记为模型组;另取未处理细胞为对照组。采用1.25、2.5、5.0 μmol/L不同浓度的连翘酯苷A处理软骨细胞,依次记为连翘酯苷A低、中、高剂量组。ELISA法检测炎症因子[IL-1β、白细胞介素-6(interleukin-6,IL-6)、肿瘤坏死因子-α(tumor necrosis factor-α,TNF-α)]水平;采用流式细胞术检测细胞凋亡率,qRT-PCR检测circSERPINE2表达量。pcDNA、pcDNA-circSERPINE2转染至软骨细胞后用IL-1β处理,si-NC、si-circSERPINE2分别转染至软骨细胞后用连翘酯苷A与IL-1β共同处理24 h,采用ELISA法检测IL-1β、IL-6、TNF-α的水平;流式细胞术检测细胞凋亡率;Western blot法检测Bax、Bcl-2蛋白表达量。结果 连翘酯苷A作用于IL-1β诱导的软骨细胞后,炎症因子(IL-1β、IL-6、TNF-α)水平、细胞凋亡率、Bax蛋白水平降低(P<0.05),Bcl-2蛋白、circSERPINE2表达水平升高(P<0.05);转染pcDNA-circSERPINE2后炎症因子(IL-1β、IL-6、TNF-α)表达水平及细胞凋亡率、Bax蛋白水平降低(P<0.05),Bcl-2蛋白水平升高(P<0.05);转染si-circSERPINE2后,炎症因子(IL-1β、IL-6、TNF-α)水平、细胞凋亡率、Bax蛋白水平升高(P<0.05),Bcl-2蛋白水平降低(P<0.05)。结论 连翘酯苷A可通过上调circSERPINE2表达而抑制细胞炎症因子表达及细胞凋亡,从而减轻IL-1β诱导的关节软骨细胞损伤。
关键词:  连翘酯苷A  circSERPINE2  白细胞介素-1β  人关节软骨细胞  炎症  细胞凋亡  Bax蛋白  Bcl-2蛋白
DOI:10.3969/j.issn.1674-070X.2023.08.009
Received:May 29, 2023  
基金项目:国家自然科学基金项目(81760620);海南省重点研发计划项目(ZDYF2021SHFZ084)。
Effects of forsythoside A on IL-1β-induced chondrocyte injury
ZHAN Hedao,YAO Jiangling,CUI Hongwang
(The First Hospital of Hainan Medical College, Haikou, Hainan 570102, China)
Abstract:
    Objective To investigate the effects of forsythoside A on IL-1β-induced chondrocyte injury and its possible mechanism of action. Methods Cell injury models of Human articular chondrocytes were established using 50 mg/L interleukin-1β (IL-1β), which were denoted as model group. The untreated chondrocytes were taken as control group. Chondrocytes treated with 1.25, 2.5 and 5.0 μmol/L forsythoside A were recorded as low-, medium- and high-dose forsythoside A groups, respectively. The levels of inflammatory factors[IL-1β, interleukin-6 (IL-6), and tumor necrosis factor-α (TNF-α)] were measured by ELISA; the apoptosis rate was determined by flow cytometry; the expression of circSERPINE2 was measured by qRT-PCR. The pcDNA and pcDNA-circSERPINE2 were separately transfected into chondrocytes which were treated with IL-1β for 24 h afterwards; the si-NC and si-circSERPINE2 were separately transfected into chondrocytes which were co-treated with forsythoside A and IL-1β for 24 h afterwards. Then, the levels of IL-1β, IL-6, and TNF-α were determined by ELISA; the apoptosis rate was measured by flow cytometry; the protein expression levels of Bax and Bcl-2 were determined by Western blot. Results After forsythoside A acting on IL-1β-induced chondrocytes, the levels of inflammatory factors (IL-1β, IL-6, and TNF-α), apoptosis rate, and Bax protein level decreased (P<0.05), while the expression levels of Bcl-2 protein and circSERPINE2 increased (P<0.05). After transfection of pcDNA-circSERPINE2, the levels of inflammatory factors (IL-1β, IL-6, and TNF-α), apoptosis rate and Bax protein level decreased (P<0.05), while Bcl-2 protein level increased (P<0.05). After transfection of si-circSERPINE2, the levels of inflammatory factors (IL-1β, IL-6, and TNF-α), apoptosis rate and Bax protein level increased (P<0.05), while Bcl-2 protein level decreased (P<0.05). Conclusion Forsythoside A could reduce IL-1β-induced chondrocyte injury by up-regulating circSERPINE2 expression and thus inhibiting the expressions of cellular inflammatory factors and apoptosis.
Key words:  forsythoside A  circSERPINE2  interleukin-1β  human articular chondrocytes  inflammation  apoptosis  Bax protein  Bcl-2 protein
本文二维码信息
二维码(扫一下试试看!)
Adress:No. 300, Xueshi Road, Hanpu Science and Education Park, Yuelu District, Changsha City, Hunan Province(410208)    Telephone0731-88458947     E-mail:xuebaotcm@126.com
Technical support :Beijing Qinyun Technology Development Co., Ltd